Utility of High-Sensitivity Modified Glasgow Prognostic Score in Cancer Prognosis: A Systemic Review and Meta-Analysis
International Journal of Molecular Sciences · 10.01.2023 · 24 (2) · 1318
DOI: 10.3390/ijms24021318 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.01.2023. Verfasst von Tsung-Hsien Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Policy and Management, National Taiwan University, Taipei 100, Taiwan. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The suitability of the high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in cancer patients remains unknown. We performed a systematic database search from 1 January 2010 to 30 September 2022, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Selected studies reported the HS-mGPS and survival outcomes in cancer patients. The association between the HS-mGPS and survival outcomes was evaluated using a random-effects model and expressed as pooled hazard ratios (HRs) with 95% CIs. This meta-analysis evaluated 17 studies with a total of 5828 cancer patients. A higher HS-mGPS was found to be associated with an adverse OS (HR = 2.17; 95% CI: 1.80–2.60), DSS (HR = 3.81; 95% CI: 2.03–7.17), and DFS (HR = 1.96; 95% CI: 1.48–2.58; all p ≤ 0.001). The prognostic value of the HS-mGPS for the OS trended in a consistent direction after subgrouping and sensitivity analysis. In conclusion, the HS-mGPS serves as a valid prognostic biomarker for cancer patients, with a high HS-mGPS associated with adverse survival outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Health Policy and Management, National Taiwan University, Taipei 100, Taiwan.
- Legal Affair Department, New Taipei City Department, New Taipei City 220242, Taiwan.
- College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
- Department of Otorhinolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Chiayi 613, Taiwan.
- School of Dentistry, National Yang Ming University, Taipei 11221, Taiwan.
- Department of Radiation Oncology, Proton and Radiation Therapy Center, Chang Gung Memorial Hospital-Linkou Medical Center, Taoyuan 333423, Taiwan.
ORCID-Profile: Wing-Keen Yap, Chih-Wei Luan
Zitieren
APA
Wu, T. H., Tsai, Y. T., Chen, K. Y., Yap, W. K., & Luan, C. W. (2023). Utility of High-Sensitivity Modified Glasgow Prognostic Score in Cancer Prognosis: A Systemic Review and Meta-Analysis. International Journal of Molecular Sciences, 24(2), 1318. https://doi.org/10.3390/ijms24021318
Vancouver
Wu TH, Tsai YT, Chen KY, Yap WK, Luan CW. Utility of High-Sensitivity Modified Glasgow Prognostic Score in Cancer Prognosis: A Systemic Review and Meta-Analysis. International Journal of Molecular Sciences. 2023;24(2):1318. doi:10.3390/ijms24021318
BibTeX
@article{Wu2023,
author = {Wu, Tsung-Hsien and Tsai, Yao-Te and Chen, Kuan-Yin and Yap, Wing-Keen and Luan, Chih-Wei},
title = {Utility of High-Sensitivity Modified Glasgow Prognostic Score in Cancer Prognosis: A Systemic Review and Meta-Analysis},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {2},
pages = {1318},
doi = {10.3390/ijms24021318}
}
EUVIMED